Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Volume 65, Number 3, August 09, 2005
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ridha, B. H.
Right arrow Articles by Rossor, M. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ridha, B. H.
Right arrow Articles by Rossor, M. N.
Related Collections
Right arrowRelated Article
NEUROLOGY 2005;65:481-482
© 2005 American Academy of Neurology
Brief Communications

Delusions and hallucinations in dementia with Lewy bodies: Worsening with memantine

B. H. Ridha, MRCP, K. A. Josephs, MST, MD and M. N. Rossor, MD, FRCP

From the Dementia Research Centre (Drs. Ridha and Rossor), National Hospital for Neurology and Neurosurgery, London, UK; Department of Neurology (Dr. Josephs), Mayo Clinic and Mayo Foundation, Rochester, MN.

Address correspondence and reprint requests to Dr. Basil Ridha, Dementia Research Centre, National Hospital for Neurology and Neurosurgery, 8-11 Queen Square, London, WC1N 3BG, UK; e-mail: bridha{at}dementia.ion.ucl.ac.uk

Three patients with probable dementia with Lewy bodies (DLB) experienced worsening delusions and visual hallucinations as a result of memantine therapy. Significant resolution occurred once treatment was discontinued. Caution is required when prescribing memantine to patients with possible DLB.

The authors report no conflicts of interest.

Received February 4, 2005. Accepted in final form April 18, 2005.


Related Article

August 9 Highlights
Neurology 2005 65: 342-343. [Full Text] [PDF]



This article has been cited by other articles:


Home page
 CMAJHome page
N. Herrmann MD and S. Gauthier MD
Diagnosis and treatment of dementia: 6. Management of severe Alzheimer disease
Can. Med. Assoc. J., December 2, 2008; 179(12): 1279 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
R. Monastero, C. Camarda, C. Pipia, and R. Camarda
Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases
J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 546 - 546.
[Full Text] [PDF]

Home page
 NeurologyHome page
C. F. Lippa, J. E. Duda, M. Grossman, H. I. Hurtig, D. Aarsland, B. F. Boeve, D. J. Brooks, D. W. Dickson, B. Dubois, M. Emre, et al.
DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers
Neurology, March 13, 2007; 68(11): 812 - 819.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
J. L. Whitwell, S. D. Weigand, M. M. Shiung, B. F. Boeve, T. J. Ferman, G. E. Smith, D. S. Knopman, R. C. Petersen, E. E. Benarroch, K. A. Josephs, et al.
Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
Brain, March 1, 2007; 130(3): 708 - 719.
[Abstract] [Full Text] [PDF]

Home page
 J PsychopharmacolHome page
A. Burns and J. O'Brien
Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology
J Psychopharmacol, November 1, 2006; 20(6): 732 - 755.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.